The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, B. M.
Right arrow Articles by Berger, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, B. M.
Right arrow Articles by Berger, M. F.
The Journal of Immunology, 1998, 161: 5147-5156.
Copyright © 1998 by The American Association of Immunologists

Anti-CD4 Monoclonal Antibody-Induced Tolerance to MHC-Incompatible Cardiac Allografts Maintained by CD4+ Suppressor T Cells That Are Not Dependent upon IL-41

Bruce M. Hall2, Lisa Fava, Juchuan Chen, Karren M. Plain, Rochelle A. Boyd, S. Timothy Spicer and Manuela F. Berger3

Department of Medicine, University of New South Wales, Liverpool Hospital, Liverpool, New South Wales, Australia

Anti-CD4 mAb-induced tolerance to transplanted tissues has been proposed as due to down-regulation of Th1 cells by preferential induction of Th2 cytokines, especially IL-4. This study examined the role of CD4+ cells and cytokines in tolerance to fully allogeneic PVG strain heterotopic cardiac allografts induced in naive DA rats by treatment with MRC Ox38, a nondepleting anti-CD4 mAb. All grafts survived >100 days but had a minor mononuclear cell infiltrate that increased mRNA for the Th1 cytokines IL-2, IFN-{gamma}, and TNF-ß, but not for Th2 cytokines IL-4 and IL-6 or the cytolytic molecules perforin and granzyme A. These hosts accepted PVG skin grafts but rejected third-party grafts, which were not blocked by anti-IL-4 mAb. Cells from these tolerant hosts proliferated in MLC and produced IL-2, IFN-{gamma}, and IL-4 at levels equivalent to naive cells. Unfractionated and CD4+ T cells, but not CD8+ T cells, transferred specific tolerance to irradiated heart grafted hosts and inhibited reconstitution of rejection by cotransferred naive cells. This transfer of tolerance was associated with normal induction of IL-2 and delayed induction of IFN-{gamma}, but not with increased IL-4 or IL-10 mRNA. Transfer of tolerance was also not inhibited by anti-IL-4 mAb. This study demonstrated that tolerance induced by a nondepleting anti-CD4 mAb is maintained by a CD4+ suppressor T cell that is not associated with preferential induction of Th2 cytokines or the need for IL-4; nor is it associated with an inability to induce Th1 cytokines or anergy.




This article has been cited by other articles:


Home page
IOVSHome page
C. F. Jessup, H. M. Brereton, P. J. Sykes, M. A. Thiel, D. J. Coster, and K. A. Williams
Local Gene Transfer to Modulate Rat Corneal Allograft Rejection
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1675 - 1681.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. R. Godfrey, D. J. Spoden, Y. G. Ge, S. R. Baker, B. Liu, B. L. Levine, C. H. June, B. R. Blazar, and S. B. Porter
Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function
Blood, January 15, 2005; 105(2): 750 - 758.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. R. Godfrey, Y. G. Ge, D. J. Spoden, B. L. Levine, C. H. June, B. R. Blazar, and S. B. Porter
In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures
Blood, July 15, 2004; 104(2): 453 - 461.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. P. Gray, P. Arosio, and P. Hersey
Association of Increased Levels of Heavy-Chain Ferritin with Increased CD4+ CD25+ Regulatory T-Cell Levels in Patients with Melanoma
Clin. Cancer Res., July 1, 2003; 9(7): 2551 - 2559.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Chen, M. S. Ford, K. J. Young, M. I. Cybulsky, and L. Zhang
Role of Double-Negative Regulatory T Cells in Long-Term Cardiac Xenograft Survival
J. Immunol., February 15, 2003; 170(4): 1846 - 1853.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Laub, R. Brecht, M. Dorsch, U. Valey, K. Wenk, and F. Emmrich
Anti-Human CD4 Induces Peripheral Tolerance in a Human CD4+, Murine CD4-, HLA-DR+ Advanced Transgenic Mouse Model
J. Immunol., September 15, 2002; 169(6): 2947 - 2955.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Chiffoleau, G. Beriou, P. Dutartre, C. Usal, J.-P. Soulillou, and M. C. Cuturi
Role for Thymic and Splenic Regulatory CD4+ T Cells Induced by Donor Dendritic Cells in Allograft Tolerance by LF15-0195 Treatment
J. Immunol., May 15, 2002; 168(10): 5058 - 5069.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. P. Gray, P. Arosio, and P. Hersey
Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells
Blood, May 1, 2002; 99(9): 3326 - 3334.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. T. Spicer, H. Ha, R. A. Boyd, X. Y. He, N. Carter, G. Tran, M. J. Penny, S. J. Hodgkinson, and B. M. Hall
IL-4 Therapy Prevents the Development of Proteinuria in Active Heymann Nephritis by Inhibition of Tc1 Cells
J. Immunol., October 1, 2001; 167(7): 3725 - 3733.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. T. Tran, N. Carter, X. Y. He, T. S. Spicer, K. M. Plain, M. Nicolls, B. M. Hall, and S. J. Hodgkinson
Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on Th1 cells that is augmented by IL-4
Int. Immunol., September 1, 2001; 13(9): 1109 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Hara, C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
J. Immunol., March 15, 2001; 166(6): 3789 - 3796.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Nicolls, M. Coulombe, H. Yang, A. Bolwerk, and R. G. Gill
Anti-LFA-1 Therapy Induces Long-Term Islet Allograft Acceptance in the Absence of IFN-{gamma} or IL-4
J. Immunol., April 1, 2000; 164(7): 3627 - 3634.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.